Oct 11 (Reuters) - Heidelberg Pharma AG WL6G.DE :
* 9-MONTH SALES REVENUE AND INCOME TOTALING EUR 3.5 MILLION
(PREVIOUS YEAR: EUR 1.6 MILLION)
* 9-MONTH SALES REVENUE OF EUR 3.1 MILLION (PREVIOUS YEAR:
EUR 1.4
MILLION)
* NET LOSS FOR FIRST NINE MONTHS OF FISCAL YEAR FELL TO EUR
7.4
MILLION (PREVIOUS YEAR: EUR 7.6 MILLION)
* EXPECTS TO GENERATE BETWEEN EUR 3.5 MILLION AND EUR 4.5
MILLION
IN SALES REVENUE AND OTHER INCOME IN 2018
* EBIT FOR 2018 FISCAL YEAR ARE PROJECTED TO BE BETWEEN EUR
-10.0
MILLION AND EUR -12.0 MILLION
Source text for Eikon: ID:nEQ9yxB40a
Further company coverage: WL6G.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))